Predictive factors of good and bad glycemic control of patients with type 2 diabetes mellitus monitored in a specialized service in Rio de Janeiro
Article Sidebar
Main Article Content
Abstract
Objective: To evaluate sociodemographic, adherence and clinical and laboratorial factors as potential predictors of good and poor glycemic control in patients diagnosed with Type 2 Diabetes Mellitus (DM2). Methods: An observational and retrospective study was carried out with 100 patients at a diabetes treatment reference center in Rio de Janeiro, which aimed to identify predictors of good and poor glycemic control in type 2 diabetic patients, during the period of 2018 to 2020. Sociodemographic, health and treatment variables were correlated with glycated hemoglobin (HbA1c) levels, stratified into QUARTILES and divided into very good, good, poor and very poor. Results: In the sample, there was a prevalence of poor glycemic control (33%) and it was observed that gender (p=0,013), age at diagnosis of diabetes (p=0,016), adherence to glycemic self-monitoring (p=0,002) and annual follow-up with an ophthalmologist (p=0,036) were the variables that were presented as predictors for the levels of glycated hemoglobin. Conclusion: The investigation of predictors of good glycemic control is important given the high prevalence of Diabetes and its complications, and it serves as a basis for more effective interventions in the treatment.
Article Details
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
References
2. AMERICAN DIABETES ASSOCIATION. Disclosures: Standards of Medical Care in Diabetes- 2020 Diabetes Care. 2020. Disponível em: https://diabetesjournals.org/care/article/43/Supplement_1/S205/30757/Disclosures-Standards-of-Medical-Care-in-Diabetes. Acessado em: 17 de abril de 2023.
3. AMERICAN DIABETES ASSOCIATION. Glycemic Targets: Standards of Medical Care in Diabetes – 2022. 2022. Disponivel em: https://diabetesjournals.org/care/article/45/Supplement_1/S83/138927/6-Glycemic-Targets-Standards-of-Medical-Care-in. Acessado em: 3 de setembro de 2023.
4. BABANIAMANSOUR S, et al. Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study. J Diabetes Metab Disord. 2020 Jul 8;19(2):933-940.
5. BERGENSTAL RM, et al. Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes. J Diabetes Complications. 2022;36(3):108106.
6. BRASIL. Pesquisa Nacional de Saúde 2019: percepção do estado de saúde, estilos de vida, doenças crônicas e saúde bucal: Brasil, grandes regiões. 2020. Disponível em: https://biblioteca.ibge.gov.br/visualizacao/livros/liv101764.pdf. Acessado em: 17 de abril de 2023
7. DEPARTMENT OF HEALTH AND HUMAN SERVICES. 2018 Physical Activity Guidelines Advisory Committee Scientific Report. 2018. Disponível em: https://health.gov/sites/default/files/2019-09/PAG_Advisory_Committee_Report.pdf. Acessado em: 17 de abril de 2023.
8. DUARTE F, et al. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela. BMJ Open. 2019;9(3): e023401.
9. FELDMAN EL. Management of diabetic neuropathy. UpToDate. Waltham, MA: UpToDate 2022.
10. FRANCISCO P, et al. Prevalence of concomitant hypertension and diabetes in Brazilian older adults: individual and contextual inequalities. Prevalência simultânea de hipertensão e diabetes em idosos brasileiros: desigualdades individuais e contextuais. Cien Saude Colet. 2018;23(11):3829-3840.
11. INTERNATIONAL DIABETES FEDERATION. IDF Diabetes Atlas, 9th edn. 2019. Disponível em: https://www.diabetesatlas.org. Acessado em: 3 de setembro de 2023
12. INZUCCHI S, LUPSA B. Clinical presentation, diagnosis, and initial evaluation of diabetes mellitus in adults. UpToDate. Waltham, MA: UpToDate 2023.
13. KUMAH E, et al. Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes. Oman Med J. 2021;36(1):e225
14. BRASIL. Vigitel Brasil 2019: Estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no distrito federal em 2019.
Disponível em: https://bvsms.saude.gov.br/bvs/publica coes/vigitel_brasil_2019_vigilancia_fatores_risco.pdf. Acessado em: 17 de abril de 2023
15. MROUEH L et al, Evaluation of medication adherence among Lebanese diabetic patients. Pharmacy practice. 2018,16(4):1291
16. SA CHOE, et al. Women are less likely than men to achieve optimal glycemic control after 1 year of treatment: A multi-level analysis of a Korean primary care cohort. PLoS One. 2018;13(5):e0196719
17. SOCIEDADE BRASILEIRA DE DIABETES. Diretrizes da sociedade Brasileira de Diabetes 2019- 2020. Disponível em: https://www.saude.ba.gov.br/wp-content/uploads/2020/02/Diretrizes-Sociedade-Brasileira-de-Diabetes-2019-2020.pdf. Acessado em: 17 de abril de 2023
18. TAN E, et al. Effect of multidisciplinary intensive targeted care in improving diabetes mellitus outcomes: a randomized controlled pilot study - the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program. Trials. 2019;20(1):549.
19. WEXLER DJ. Initial management of hyperglycemia in adults with type 2 diabetes mellitus. UpToDate. Waltham, MA: UpToDate 2022.
20. WEXLER DJ. Overview of general medical care in nonpregnant adults with diabetes mellitus. UpToDate. Waltham, MA: UpToDate 2023.
21. WEXLER L, et al. Management of persistent hyperglycemia in type 2 diabetes mellitus. UpToDate. Waltham, MA: UpToDate, 2023.